plaque psoriasis

Stelara (Ustekinumab) has been approved for the treatment of psoriasis, Crohn’s disease, ulcerative colitis, plaque psoriasis and…

JNJ-2113, a novel, first-in-class oral interleukin 23 receptor (IL-23R) antagonist peptide in adult patients with…

Bimzelx is set to become a blockbuster for the treatment of these debilitating, chronic conditions, with a global sales forecast…

This approval in China follows the recent approval of Cosentyx in the United States and Europe for the treatment of…

Apremilast tablets are indicated for the treatment of plaque psoriasis

SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis,…

ILUMYA is approved for adults with moderate-to-severe plaque psoriasis and is being evaluated for other possible uses

It is indicated for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies…

ILUMYA is one of the key specialty products of Sun Pharma and it was approved by US FDA in March 2018 while the European…

Reportedly, updated cost analysis reveals ILUMYA is among the most cost-effective first-line treatments for moderate-to-severe…